2016³â ´ëÇѾÏÇÐȸ Çмú»ó ¼ö»óÀÚ ¸í´Ü | |||
1. Á¦ 19ȸ Çѱ¹¾Ï¿¬±¸Àç´Ü Çмú»ó (¾ÏÇÐȸÁö¿¡ °ÔÀçµÈ ±âÃÊ³í¹®) | |||
No. | ÀúÀÚ ¹× ¼Ò¼Ó | Á¦ ¸ñ | |
1 | ¼¿ïÀÇ´ë ³»°ú ÀÓ¼®¾Æ |
TGF-¥â Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells | |
2. Á¦ 8ȸ ´ëÇѾÏÇÐȸ ±âÃÊ¿ì¼ö³í¹®»ó (¾ÏÇÐȸÁö¿¡ °ÔÀçµÈ ±âÃÊ³í¹®) | |||
No. | ÀúÀÚ ¹× ¼Ò¼Ó | Á¦ ¸ñ | |
1 | ¿ø±¤ÀÇ´ë ³»°ú ±èÇÐ·Ä |
Synergistic Effect of Sulindac and Simvastatin on Apoptosis in Lung Cancer A549 Cells through AKT-Dependent Downregulation of Survivin | |
2 | ±¹¸³¾Ï¼¾ÅÍ ½Å°æ¿Ü°ú °ûÈ£½Å |
Radiation-Induced Autophagy Contributes to Cell Death and Induces Apoptosis Partly in Malignant Glioma Cells | |
3. Á¦ 6ȸ ¸ÓÅ©¼¼·Î³ë Çмú»ó (¾ÏÇÐȸÁö¿¡ °ÔÀçµÈ ÀÓ»ó³í¹® Áß ´ëÀå¾Ï ¶Ç´Â µÎ°æºÎ ³í¹®) | |||
No. | ÀúÀÚ ¹× ¼Ò¼Ó | Á¦ ¸ñ | |
1 | °í·ÁÀÇ´ë ³»°ú ±è¿È« |
Can Serum be Used for Analyzing the KRASMutation Status in Patients with Advanced Colorectal Cancer? | |
2 | ±¹¸³¾Ï¼¾ÅÍ ´ëÀå¾Ï¿¬±¸°ú À¯º´Ã¶ |
Identification of Hypoxanthine and Phosphoenolpyruvic Acid as Serum Markers of Chemoradiotherapy Response in Locally Advanced Rectal Cancer | |
3 | ¿¬¼¼ÀÇ´ë ³»°ú ½Å»óÁØ |
Novel Methods for Clinical Risk Stratification in Patients with Colorectal Liver Metastases | |
4. Á¦ 8ȸ ·Î½´ ¾ÏÇмú»ó (¾ÏÇÐȸÁö¿¡ °ÔÀçµÈ ÀÓ»ó & Translational ³í¹® 10Æí) | |||
No | ¼Ò ¼Ó | Á¦ ¸ñ | |
1 | Á¦ÁÖÀÇ´ë ¿¹¹æÀÇÇб³½Ç ¹èÁ¾¸é |
Optimal Interval for Repeated Gastric Cancer Screening in Normal-Risk Healthy Korean Adults: A Retrospective Cohort Study | |
2 | ±¹¸³¾Ï¼¾ÅÍ ¾ÏÅë°è°ú Á¤±Ô¿ø |
Age-Period-Cohort Analysis of Thyroid Cancer Incidence in Korea | |
3 | »ï¼º¼¿ïº´¿ø ³»°ú ±è¼®Áø |
Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis | |
4 | ¿¬¼¼¿øÁÖÀÇ´ë º´¸®°ú Á¶¹Ì¿¬ |
Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters | |
5 | ±¹¸³¾Ï¼¾ÅÍ ¿Ü°ú ÀÌÀº¼÷ |
The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea | |
6 | ¼¿ïÀÇ´ë ³»°ú ¹Ú¼¼ÈÆ |
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations | |
7 | °¡Å縯ÀÇ´ë º´¸®°ú À¯Áø¿µ |
Identification of EGFRMutations by Immunohistochemistry with EGFRMutation–Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma | |
8 | °¡Å縯ÀÇ´ë ¹æ»ç¼±Á¾¾ç ±è¿¬½Ç |
Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis | |
9 | ±¹¸³¾Ï¼¾ÅÍ °£¾Ï¼¾ÅÍ ¹ÚÁß¿ø |
Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma | |
10 | »ï¼º¼¿ïº´¿ø ¹æ»ç¼±Á¾¾ç ¹ÚÈñö |
Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy | |
5. Á¦ 5ȸ ±¤µ¿¾ÏÇмú»ó | |||
1) ÃÖ°í IF SCI ÇмúÁö¿¡ ¾ÏÇÐȸÁö¸¦ ÀοëÇÏ¿© ³í¹®À» ¹ßÇ¥ÇÑ ±âÃÊ ¹× ÀÓ»ó³í¹®ÀÇ Ã¥ÀÓÀúÀÚ °¢ 1¸í | |||
No. | ÀúÀÚ ¹× ¼Ò¼Ó | Á¦ ¸ñ | |
1 | ¼¿ïÀÇ´ë ³»°ú ¹æ¿µÁÖ |
Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer | J CLIN ONCOL. 2015;33:3858-65 (IF 18.428, 2014) |
2 | »ï¼º¼¿ïº´¿ø ³»°ú ¹Ú±ÙÄ¥ |
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04 | J CLIN ONCOL. 2015;33:2660-6 (IF 18.428, 2014) |
3 | °¡Å縯°üµ¿´ë ¿¹¹æÀÇÇб³½Ç ÀÌ»ó¿í |
Sex-age-specific association of body mass index with all-cause mortality among 12.8 million Korean adults: a prospective cohort study | Int J Epidemiol. 2015;55:1696-705 (IF 9.176, 2014) |
2) ´Ù¼öÀÇ SCI µîÀç ÇмúÁö¿¡ ¾ÏÇÐȸÁö¸¦ ÀοëÇÏ¿© ³í¹®À» ¹ßÇ¥ÇÑ Ã¥ÀÓÀúÀÚ 1¸í | |||
No. | ÀúÀÚ ¹× ¼Ò¼Ó | Á¦ ¸ñ | |
1 | ±¹¸³¾Ï¼¾ÅÍ ¾Ïµî·Ï»ç¾÷°ú ¿ø¿µÁÖ |
Prognosis of Cervical Cancer in the Era of Concurrent Chemoradiation from National Database in Korea: A Comparison between Squamous Cell Carcinoma and Adenocarcinoma | PLoS One. 2015;10:e0144887 |
Elevated Risks of Subsequent Primary Malignancies in Patients With Thyroid Cancer: A Nationwide, Population-Based Study in Korea. | Cancer. 2015; 121(2):259-68 |
||
Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010) | PLoS One. 2015;10:e0134160. |
||
Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study | PLoS One. 2015;10:e0140693 |
||
Lung cancer risk in professional drivers in Korea: A population-based proportionate cancer incidence ratio study | J Occup Health. 2015;57:324-30 |
||
6. Á¦2ȸ Merit Award | |||
¸Å³â 6¿ù ´ëÇѾÏÇÐȸ ¿¬·ÊÇмú´ëȸ¿¡¼ ¹ßÇ¥µÇ´Â ÃÊ·Ï Áß ¿ì¼ö ÃÊ·Ï 15Æí (1µî 1¸í, 2µî 2¸í, 3µî 12¸í) |
|||
No. | ¼ö»óÀÚ | ÃÊ·ÏÁ¦¸ñ | |
1 | °¡Å縯ÀÇ´ë »êºÎÀΰú ÃÖÀ±Áø |
Intra-individual genomic heterogeneity of serous adenocarcinoma of ovary and clinical utility of ascitic cancer cells for mutation profiling | |
2 | ±¹¸³¾Ï¼¾ÅÍ ³»°ú ¹ÚÀÎÇý |
Tumor derived IL-18 induced PD-1 expressed immunosuppressive NK cells in triple negative breast cancer | |
3 | ¿ï»ê´ëÇб³ Vo Mai Tram |
Tristetraprolin inhibits mitochondrial function through suppression of a-Synuclein expression in cancer cells | |
4 | ¾ÆÁÖÀÇ´ë À̺ñÀÎÈÄ°ú ±èöȣ |
HSPA5 regulates signaling switch from pro-survival to pro-apoptosis through lysosome inhibition in head and neck cancer | |
5 | ¼º±Õ°üÀÇ´ë »êºÎÀΰú ±è¿µÁØ |
Histone 3 lysine 4 methylase and histone 3 lysine 27 demethylase as histone-modifying enzyme reduces the expression of O6-methylguanine DNA methyltrasferase in glioblastoma | |
6 | °æºÏÀÇ´ë ³»°ú À̼öÁ¤ |
Prognostic impact of Del-1 expression in early breast cancer | |
7 | °í·Á´ëÇб³ ÀÇ°úÇבּ¸Áö¿ø¼¾ÅÍ ÀÌÁ¾¿ø |
Identification of characteristics and target genes in diffuse and intestinal type gastric cancer stem-like cells | |
8 | ºÐ´ç¼¿ï´ëº´¿ø º´¸®°ú ±èÈ¿Áø |
Prognostic significance of stem cell-related Marker expression and its correlation with histologic subtypes in lung adenocarcinoma | |
9 | °æºÏÀÇ´ë ³»°ú °º´¿í |
Clinical significance of microRNA expression in patients with epstein-barr virus associated gastric cancer | |
10 | »ï¼º¼¿ïº´¿ø º´¸®°ú ÃÖÀ±¶ó |
Analysis of somatic genome rearrangements in human cancers by whole exome sequencing | |
11 | ¼º±Õ°ü´ëÇб³ À¶ÇÕÀÇ°úÇаú ³ë°¡¿ø |
The molecular breakdown: A comprehensive look into non–small-cell lung cancer with ALK rearrangement | |
12 | ¿¬¼¼ÀÇ´ë ³»°ú ±èâ°ï |
PNA clamping-assisted fluorescence melting curve analysis detect activating and acquired resistance in plasma from EGFR mutated NSCLC patients after EGFR-TKI | |
13 | °æºÏÀÇ´ë ³»°ú ÀÌÀÎÈñ |
Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer | |
14 | Àü³²ÀÇ´ë ¿Ü°ú ¹Ú¿ë±Ô |
Laparoscopy-assisted versus open D2 distal gastrectomy for advanced gastric cancer: results from a randomized phase II multicenter clinical trial | |
15 | »ï¼º¼¿ïº´¿ø ³»°ú ¾È¸íÁÖ |
Osimertinib in patients with T790M positive advanced non-small cell lung cancer: Korean subgroup analysis from pooled phase II data |